Incorporating molecular shape into the alignment-free GRid-INdependent descriptors

Journal of Medicinal Chemistry

Volumn 47, Issue 11, 2004, Pages 2805-2815

  Fontaine, Fabien ^a   Pastor, Manuel ^a   Sanz, Ferran ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE A1 RECEPTOR ANTAGONIST; LIGAND; PLASMEPSIN II; XANTHINE;

ANALYTIC METHOD; ARTICLE; CHEMICAL STRUCTURE; MOLECULE; NONHUMAN; PLASMODIUM FALCIPARUM; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ANIMALS; ASPARTIC ENDOPEPTIDASES; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; PLASMODIUM FALCIPARUM; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; RECEPTOR, ADENOSINE A1; XANTHINES;

EID: 2442659094     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0311240     Document Type: Article

References (43)

1. Hansch, C. A quantitative approach to biochemical structure-activity relationships. Acc. Chem. Res. 1969, 2, 232-239.
2. Cramer, R. D.; Patterson, D. E.; Bunce, J. D. Comparative Molecular Field Analysis (CoMFA): 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
3. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146.
4. Cruciani, G.; Watson, K. A. Comparative molecular field analysis using GRID force-field and GOLPE variable selection methods in a study of inhibitors of glycogen phosphorylase b. J. Med. Chem. 1994, 37, 2589-2601.
5. Cramer, R. D. Topomer CoMFA: a design methodology for rapid lead optimization. J. Med. Chem. 2003, 46, 374-388.
6. Pastor, M.; Cruciani, G.; McLay, I.; Pickett, S.; Clementi, S. GRid-INdependent descriptors (GRIND): a novel class of alignment-independent three-dimensional molecular descriptors. J. Med. Chem. 2000, 43, 3233-3243.
7. Goodford, P. J. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. J. Med. Chem. 1985, 28, 849-857.
8. Carey, R. N.; Wold, S.; Westgard, J. O. Principal component analysis: an alternative to "referee" methods in method comparison studies. Anal. Chem. 1975, 47, 1824-1829.
9. Hoskuldsson, A. PLS regression methods. J Chemom. 1988, 2, 211-228.
10. Benedetti, P.; Mannhold, R.; Cruciani, G.; Pastor, M. GBR compounds and mepyramines as cocaine abuse therapeutics: chemometric studies on selectivity using grid independent descriptors (GRIND). J. Med. Chem. 2002, 45, 1577-1584.
11. Afzelius, L.; Masimirembwa, C. M.; Karlen, A.; Andersson, T. B.; Zamora, I. Discriminant and quantitative PLS analysis of competitive CYP2C9 inhibitors versus non-inhibitors using alignment independent GRIND descriptors. J. Comput.-Aided Mol. Des. 2002, 16, 443-458.
12. Brea, J.; Masaguer, C. F.; Villazon, M.; Cadavid, M. I.; Ravina, E.; et al. Conformationally constrained butyrophenones as new pharmacological tools to study 5-HT 2A and 5-HT 2C receptor behaviours. Eur. J. Med. Chem. 2003, 38, 433-440.
13. Cruciani, G.; Pastor, M.; Mannhold, R. Suitability of molecular descriptors for database mining. A comparative analysis. J. Med. Chem. 2002, 45, 2685-2694.
14. Fontaine, F.; Pastor, M.; Gutierrez-De-Teran, H.; Lozano, J. J.; Sanz, F. Use of alignment-free molecular descriptors in diversity analysis and optimal sampling of molecular libraries. Mol. Diversity 2003, 6, 135-147.
15. Ajay; Murcko, M. A. Computational methods to predict binding free energy in ligand-receptor complexes. J. Med. Chem. 1995, 38, 4953-4967.
16. Hall, L. H.; Kier, L. B. The molecular connectivity Chi indexes and Kappa shape indexes in structure-property modeling. Reviews in Computational Chemistry; VCH Publishers: New York, 1991; pp 367-422.
17. Lemmen, C.; Lengauer, T. Computational methods for the structural alignment of molecules. J. Comput.-Aided Mol. Des. 2000, 14, 215-232.
18. Good, A. C.; Kuntz, I. D. Investigating the extension of pairwise distance pharmacophore measures to triplet-based descriptors. J. Comput.-Aided Mol. Des. 1995, 9, 373-379.
19. Nilakantan, R.; Bauman, N.; Venkataraghavan, R. New method for rapid characterization of molecular shapes: applications in drug design. J. Chem. Inf. Comput. Sci. 1993, 33, 79-85.
20. Kotani, T.; Higashiura, K. Rapid evaluation of molecular shape similarity index using pairwise calculation of the nearest atomic distances. J. Chem. Inf. Comput. Sci. 2002, 42, 58-63.
21. Cosgrove, D. A.; Bayada, D. M.; Johnson, A. P. A novel method of aligning molecules by local surface shape similarity. J. Comput.-Aided Mol. Des. 2000, 14, 573-591.
22. Kearsley, S. An alternative method for the alignment of molecular structures: Maximizing electrostatic and steric overlap. Tetrahedron Comput. Methodol. 1990, 3, 615-633.
23. Waller, C. L.; Oprea, T. I.; Chae, K.; Park, H.-K.; Korach, K. S.; et al. Ligand-based identification of environmental estrogens. Chem. Res. Toxicol. 1996, 9, 1240-1248.
24. Strappaghetti, G.; Corsano, S.; Barbaro, R.; Giannaccini, G.; Betti, L. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists. Bioorg. Med. Chem. 2001, 9, 575-583.
25. Carroll, C. D.; Patel, H.; Johnson, T. O.; Guo, T.; Orlowski, M.; et al. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg. Med. Chem. Lett. 1998, 8, 2315-2320.
26. Lee, B.; Richards, F. M. The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. 1971, 55, 379-400.
27. Greer, J.; Bush, B. L. Macromolecular shape and surface maps by solvent exclusion. Proc. Natl. Acad. Sci. U.S.A. 1978, 75, 303-307.
28. Richards, F. M. Areas, volumes, packing and protein structure. Annu. Rev. Biophys. Bioeng. 1977, 6, 151-176.
29. Connolly, M. L. Analytical molecular surface calculation. J. Appl. Crystallogr. 1983, 16, 548-558.
30. Walker, P. D.; Arteca, G. A.; Mezey, P. G. A complete shape characterization for molecular charge densities represented by Gaussian-type functions. J. Comput. Chem. 1991, 12, 220-230.
31. Cruciani, G.; Fontaine, F.; Pastor, M. Almond, 3.2.0; Molecular Discovery Ltd.: Perugia, Italy.
32. Gasteiger, J.; Rudolph, C.; Sadowski, J. Automatic generation of 3D atomic coordinates for organic molecules. Tetrahedron Comput. Methodol. 1990, 3, 537-547.
33. Fontaine, F.; Pastor, M.; Sanz, F. Potential usefulness of the GRIND descriptors for obtaining 3D-QSAR models without supervision. Presented at the XIIth National Congress of the Spanish Society of Medicinal Chemistry, Sevilla, Spain, 2001; Poster.
34. Müller, C.; Stein, B. Adenosine receptor antagonists: Structures and potential therapeutic applications. Curr. Pharm. Des. 1996, 2, 501-530.
35. Fredholm, B. B.; Ijzerman, A. P.; Jacobson, K. A.; Klotz, K. N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 2001, 53, 527-552.
36. Poulsen, S. A.; Quinn, R. J. Adenosine receptors: new opportunities for future drugs. Bioorg. Med. Chem. 1998, 6, 619-641.
37. Haas, H. L.; Selbach, O. Functions of neuronal adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol. 2000, 362, 375-381.
38. Suzuki, F.; Shimada, J.; Mizumoto, H.; Karasawa, A.; Kubo, K.; et al. Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. J. Med. Chem. 1992, 35, 3066-3075.
39. Nezami, A.; Luque, I.; Kimura, T.; Kiso, Y.; Freire, E. Identification and characterization of allophenylnorstatine-based inhibitors of plasmepsin II, an antimalarial target. Biochemistry 2002, 41, 2273-2280.
40. Coombs, G. H.; Goldberg, D. E.; Klemba, M.; Berry, C.; Kay, J.; et al. Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets. Trends Parasitol. 2001, 17, 532-537.
41. Nezami, A.; Kimura, T.; Hidaka, K.; Kiso, A.; Liu, J.; et al. High-affinity inhibition of a family of Plasmodium falciparum proteases by a designed adaptive inhibitor. Biochemistry 2003, 42, 8459-8464.
42. Silva, A. M.; Lee, A. Y.; Gulnik, S. V.; Maier, P.; Collins, J.; et al. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 10034-10039.
43. Baldwin, E. T.; Bhat, T. N.; Gulnik, S.; Hosur, M. V.; Sowder, R. C., 2nd; et al. Crystal structures of native and inhibited forms of human cathepsin D: implications for lysosomal targeting and drug design. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 6796-6800.